# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-26-193939
Filing Date
2026-04-30
Accepted
2026-04-30 07:03:34
Documents
1
Period of Report
2025-12-31
Effectiveness Date
2026-04-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | ars_10-k_2025.pdf | ARS | 1249437
| Complete submission text file | 0001193125-26-193939.txt |  | 1722298

Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879
Lexeo Therapeutics, Inc. (Filer) CIK: 0001907108 (see all company filings)

EIN.: 854012572 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-41855 | Film No.: 26920011
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)